Switch to
More onapp

How to use scorecard? Learn more

Piramal Pharma Ltd

PPLPHARMA
Health CarePharmaceuticals
SmallcapWith a market cap of ₹18,378 cr, stock is ranked 323
High RiskStock is 3.62x as volatile as Nifty
139.452.40 (-1.69%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹18,378 cr, stock is ranked 323
High RiskStock is 3.62x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
-551.25
PB RatioPB Ratio
2.71
Dividend YieldDiv. Yield
Sector PESector PE
51.18
Sector PBSector PB
5.82
Sector Div YldSctr Div Yld
0.57%

Forecast & RatingsDetailed Forecast 

100%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Piramal Pharma Ltd is a manufacturer of pharmaceutical preparation. It offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 14 global facilities and a global distribution network in over 100 countries. The Company is located in Mumbai, India.

Investor PresentationView older 

Aug 3, 2023

PDF
View Older Presentations

Financial TrendFinancial statements 

2021202220236.546.897.360.840.38-0.19
Revenue
Profit
Loss
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Increased Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has increased by 2.48%

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Press Release 
Announced OnApr 10, 2024

Piramal Pharma Limited has informed the Exchange regarding a press release dated April 10, 2024, titled "Press Release Piramal Pharma Limited ( the Company ) forays into men s grooming market with the launch of BOHEM". | Download

Piramal Pharma Limited has informed the Exchange regarding a press release dated April 10, 2024, titled "Press Release Piramal Pharma Limited ( the Company ) forays into men s grooming market with the launch of BOHEM". | Download

See all events